1-20 of 41
Steven A. Rosenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma

Shoshana T. Levi, Amy R. Copeland, Shirley Nah, Jessica S. Crystal, Gabriel D. Ivey, Almin Lalani, Mohammad Jafferji, Bradley S. White, Neilesh B. Parikh, Vid Leko, Sri Krishna, Frank Lowery, Todd D. Prickett, Jared J. Gartner, Li Jia, Yong F. Li, Abraham Sachs, Sivasish Sindiri, Welles Robinson, Billel Gasmi, James C. Yang, Stephanie L. Goff, Steven A. Rosenberg, Paul F. Robbins
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3042–3052.
https://doi.org/10.1158/1078-0432.CCR-21-4499
Published: 15 July 2022
View article titled, Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma
Open the PDF for Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma

Samantha J. Seitter, Richard M. Sherry, James C. Yang, Paul F. Robbins, Mackenzie L. Shindorf, Amy R. Copeland, Christine T. McGowan, Monica Epstein, Thomas E. Shelton, Michelle M. Langhan, Zulmarie Franco, David N. Danforth, Donald E. White, Steven A. Rosenberg, Stephanie L. Goff
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5289–5298.
https://doi.org/10.1158/1078-0432.CCR-21-1171
Published: 01 October 2021
View article titled, Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Open the PDF for Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy

Noam Levin, Biman C. Paria, Nolan R. Vale, Rami Yossef, Frank J. Lowery, Maria R. Parkhurst, Zhiya Yu, Maria Florentin, Gal Cafri, Jared J. Gartner, Mackenzie L. Shindorf, Lien T. Ngo, Satyajit Ray, Sanghyun P. Kim, Amy R. Copeland, Paul F. Robbins, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5084–5095.
https://doi.org/10.1158/1078-0432.CCR-21-0849
Published: 15 September 2021
View article titled, Identification and Validation of T-cell Receptors Targeting <em>RAS</em> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
Open the PDF for Identification and Validation of T-cell Receptors Targeting <em>RAS</em> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens

Parisa Malekzadeh, Rami Yossef, Gal Cafri, Biman C. Paria, Frank J. Lowery, Mohammad Jafferji, Meghan L. Good, Abraham Sachs, Amy R. Copeland, Sanghyun P. Kim, Scott Kivitz, Maria R. Parkhurst, Paul F. Robbins, Satyajit Ray, Liqiang Xi, Mark Raffeld, Zhiya Yu, Nicholas P. Restifo, Robert P.T. Somerville, Steven A. Rosenberg, Drew C. Deniger
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (6): 1267–1276.
https://doi.org/10.1158/1078-0432.CCR-19-1874
Published: 13 March 2020
View article titled, Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
Open the PDF for Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens in another window
Includes: Supplementary data
Journal Articles

BRAF Inhibition: Bridge or Boost to T-cell Therapy?

Stephanie L. Goff, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2682–2684.
https://doi.org/10.1158/1078-0432.CCR-19-0286
Published: 01 May 2019
View article titled, BRAF Inhibition: Bridge or Boost to T-cell Therapy?
Open the PDF for BRAF Inhibition: Bridge or Boost to T-cell Therapy? in another window
Journal Articles

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

Sanja Stevanović, Sarah R. Helman, John R. Wunderlich, Michelle M. Langhan, Stacey L. Doran, Mei Li M. Kwong, Robert P.T. Somerville, Christopher A. Klebanoff, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1486–1493.
https://doi.org/10.1158/1078-0432.CCR-18-2722
Published: 01 March 2019
View article titled, A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
Open the PDF for A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers in another window
Includes: Supplementary data
Journal Articles

T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Drew C. Deniger, Anna Pasetto, Paul F. Robbins, Jared J. Gartner, Todd D. Prickett, Biman C. Paria, Parisa Malekzadeh, Li Jia, Rami Yossef, Michelle M. Langhan, John R. Wunderlich, David N. Danforth, Robert P.T. Somerville, Steven A. Rosenberg
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (22): 5562–5573.
https://doi.org/10.1158/1078-0432.CCR-18-0573
Published: 15 November 2018
View article titled, T-cell Responses to <em>TP53</em> “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Open the PDF for T-cell Responses to <em>TP53</em> “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers in another window
Includes: Supplementary data
Journal Articles

Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer

Yasmine Assadipour, Nikolaos Zacharakis, Jessica S. Crystal, Todd D. Prickett, Jared J. Gartner, Robert P.T. Somerville, Hui Xu, Mary A. Black, Li Jia, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John R. Wunderlich, Zhili Zheng, Yong-Chen Lu, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4347–4353.
https://doi.org/10.1158/1078-0432.CCR-16-1423
Published: 01 August 2017
View article titled, Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
Open the PDF for Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, Paul A. Beavis, Jennifer A. Westwood, Sherly Mardiana, David C. Tscharke, Sarah Ellis, H. Miles Prince, Joseph A. Trapani, Ricky W. Johnstone, Mark J. Smyth, Michele W. Teng, Aesha Ali, Zhiya Yu, Steven A. Rosenberg, Nicholas P. Restifo, Paul Neeson, Phillip K. Darcy, Michael H. Kershaw
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (10): 2478–2490.
https://doi.org/10.1158/1078-0432.CCR-16-1860
Published: 14 May 2017
View article titled, Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
Open the PDF for Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting in another window
Includes: Supplementary data
Journal Articles

Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

Maria Parkhurst, Alena Gros, Anna Pasetto, Todd Prickett, Jessica S. Crystal, Paul Robbins, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (10): 2491–2505.
https://doi.org/10.1158/1078-0432.CCR-16-2680
Published: 14 May 2017
View article titled, Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Open the PDF for Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression in another window
Includes: Supplementary data
Journal Articles

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Drew C. Deniger, Mei Li M. Kwong, Anna Pasetto, Mark E. Dudley, John R. Wunderlich, Michelle M. Langhan, Chyi-Chia Richard Lee, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 351–362.
https://doi.org/10.1158/1078-0432.CCR-16-0906
Published: 15 January 2017
View article titled, A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Open the PDF for A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma in another window
Journal Articles

Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

Liqiang Xi, Trinh Hoc-Tran Pham, Eden C. Payabyab, Richard M. Sherry, Steven A. Rosenberg, Mark Raffeld
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (22): 5480–5486.
https://doi.org/10.1158/1078-0432.CCR-16-0613
Published: 14 November 2016
View article titled, Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
Open the PDF for Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

CCR 20th Anniversary Commentary: Autologous T Cells—The Ultimate Personalized Drug for the Immunotherapy of Human Cancer

Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5409–5411.
https://doi.org/10.1158/1078-0432.CCR-14-3131
Published: 14 December 2015
View article titled, <em>CCR</em> 20<sup>th</sup> Anniversary Commentary: Autologous T Cells—The Ultimate Personalized Drug for the Immunotherapy of Human Cancer
Open the PDF for <em>CCR</em> 20<sup>th</sup> Anniversary Commentary: Autologous T Cells—The Ultimate Personalized Drug for the Immunotherapy of Human Cancer in another window
Journal Articles

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

Lindsey M. Draper, Mei Li M. Kwong, Alena Gros, Sanja Stevanović, Eric Tran, Sid Kerkar, Mark Raffeld, Steven A. Rosenberg, Christian S. Hinrichs
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4431–4439.
https://doi.org/10.1158/1078-0432.CCR-14-3341
Published: 30 September 2015
View article titled, Targeting of HPV-16<sup>+</sup> Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
Open the PDF for Targeting of HPV-16<sup>+</sup> Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6 in another window
Includes: Supplementary data
Journal Articles

Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

Ling Zhang, Richard A. Morgan, Joal D. Beane, Zhili Zheng, Mark E. Dudley, Sadik H. Kassim, Azam V. Nahvi, Lien T. Ngo, Richard M. Sherry, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Steven A. Feldman, Mary Ann Toomey, Sid P. Kerkar, Nicholas P. Restifo, James C. Yang, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2278–2288.
https://doi.org/10.1158/1078-0432.CCR-14-2085
Published: 14 May 2015
View article titled, Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Open the PDF for Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James C. Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi-Chia R. Lee, Yong F. Li, Mona El-Gamil, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1019–1027.
https://doi.org/10.1158/1078-0432.CCR-14-2708
Published: 01 March 2015
View article titled, A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Open the PDF for A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response in another window
Includes: Supplementary data
Journal Articles

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 534–543.
https://doi.org/10.1158/1078-0432.CCR-14-2208
Published: 01 February 2015
View article titled, Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
Open the PDF for Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans in another window
Includes: Supplementary data
Journal Articles

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

Yong-Chen Lu, Xin Yao, Jessica S. Crystal, Yong F. Li, Mona El-Gamil, Colin Gross, Lindy Davis, Mark E. Dudley, James C. Yang, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3401–3410.
https://doi.org/10.1158/1078-0432.CCR-14-0433
Published: 30 June 2014
View article titled, Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Open the PDF for Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions in another window
Includes: Supplementary data
Journal Articles

Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Edmund K. Bartlett, Patricia A. Fetsch, Armando C. Filie, Andrea Abati, Seth M. Steinberg, John R. Wunderlich, Donald E. White, Daniel J. Stephens, Francesco M. Marincola, Steven A. Rosenberg, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (10): 2607–2616.
https://doi.org/10.1158/1078-0432.CCR-13-2690
Published: 14 May 2014
View article titled, Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
Open the PDF for Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration in another window
Includes: Supplementary data
Journal Articles

EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

John H. Sampson, Bryan D. Choi, Luis Sanchez-Perez, Carter M. Suryadevara, David J. Snyder, Catherine T. Flores, Robert J. Schmittling, Smita K. Nair, Elizabeth A. Reap, Pamela K. Norberg, James E. Herndon, II, Chien-Tsun Kuan, Richard A. Morgan, Steven A. Rosenberg, Laura A. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (4): 972–984.
https://doi.org/10.1158/1078-0432.CCR-13-0709
Published: 16 February 2014
View article titled, EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
Open the PDF for EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss in another window